All Type of News
Minister Jin-yup Jung, “I will not accept the doctor-to-patient telemedicine”
Jin-yup Jung, Minister of Health and Welfare, expressed an opinion that he has no intention of accepting doctor-to-patient telemedicine, which exceeds the current doctor-to-doctor telemedicine allowed under the curren...
Green Cross becomes the fourth company succeeding in acquisition of tetravalent vaccine approvalOn the 26th, Green Cross(CEO Eun-cheol Huh) announced acquisition of product approval of G C Flu Pre-filled Syringe Inj, a tetravalent influenza(flu) vaccine, from the Ministry ...
|
President Jae-seung Yoon dominates the governing system of Daewoong groupThe complicated composition of Daewoong Pharmaceutical’s market share among siblings has been organized by the independence of its former vice president, Jae-hoon Yoon(53).
As ...
|
Dong Wha starts to develop first generic of Champix, antismoking treatmentDong Wha Pharm has started to develop generics of Champix, an antismoking treatment. Among the domestic companies which filed patent lawsuits of Champix against Pfizer, the orig...
|
Lower income group tends more to experience overburdened medical expenses
It was known the ratio of medical expenses(patient-sharing amounts) to living expenses of Korean families have continuously been increased and the lower income and more chronic disease patients they have, the higher c...
DAA and new agents were included in the revised hepatitis C guideline
“Research papers have been accumulated and its related data were added even while we were preparing for the revision of the guideline. That is, hepatitis C faces a new treatment paradigm.”
It was an impression of Pro...
Listed pharmaceutical companies’ sales management expenses about to go under 30%
This year, the average sales management expense ratios to sales decreased to less than 30% among listed pharmaceutical in the KOSPI and the same ratio of KOSDAQ listed pharmaceutical companies has still remained above...
MFDS, “We will consider biomedicines to be applied by the PIC/S benefit”
The Ministry of Food and Drug Safety(MFDS) has considered a plan to apply the benefit of being a PIC/S member country to biopharmaceutical products.
The Ministry of Food and Drug Safety announced the plan above as a ...
Twynsta, Lantus and Vytorin are about to be expired in patent
This year, patent expirations of gigantic products, such as ‘Celebrex,’ an anti-inflammatory drug, ‘Cialis,’ an erectile dysfunction treatment, and ‘Baraclude,’ a hepatitis B treatment, have triggered fierce generic c...
‘Detailed’ regulations to support academic conferences by KPMA
After informing the pharmaceutical association of the supporting scale and details of an international symposium held by an academic society in Korea, a pharmaceutical company supported expenses of the symposium direc...
